LP
CTIC

LMR Partners’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

LMR Partners’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-71,918
Closed -$336K – 1593
2022
Q1 		$336K Buy
+71,918
New +$214K ﹤0.01% 1055
2021
Q2 		– Sell
-37,769
Closed -$110K – 1596
2021
Q1 		$110K Buy
+37,769
New +$123K ﹤0.01% 852
2019
Q4 		– Sell
-54,931
Closed -$46K – 645
2019
Q3 		$46K Hold
54,931
– – ﹤0.01% 379
2019
Q2 		$47K Buy
+54,931
New +$50.7K ﹤0.01% 380
2016
Q3 		– Sell
-23,505
Closed -$80K – 595
2016
Q2 		$80K Buy
+23,505
New +$108K 0.01% 413
2014
Q2 		– Sell
-10,364
Closed -$352K – 655
2014
Q1 		$352K Buy
+10,364
New +$354K 0.05% 169

Other funds holding CTIC

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $114M AUM 77.6% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2B AUM 117.41% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return